Which Pharmaceutical Companies are Seen as Leaders?

By Tyler Hassman, CEO

May 29, 2017

Corporate reputation plays an important role in enabling companies to further differentiate their products in highly competitive markets. As a result our team sought to better understand how pharmaceutical manufacturers are currently perceived. After surveying Canadian GPs, we noticed several trends. One of which was when assessing overall pharma leadership, there was no unanimous leader. However, when asked about specific therapeutic areas, GP perceptions of leadership varied for different companies.

Read More

We asked 180 Canadian physicians of which pharmaceutical company they have the highest opinion. Overall, there was no clear winner. However, when asked by disease areas, some leaders emerge.

Top companies seen as leader in…(% ranked 1-3)

  • Neurology: Novartis (46%); Roche (38%); Lilly (37%)
  • Cardiovascular Disease: Merck (51%); AstraZeneca (43%); Pfizer (43%)
  • Respiratory: GSK (69%); AstraZeneca (67%); Boehringer Ingelheim (56%)
  • Gastroenterology: Merk (67%); Pfizer (61%); Janssen (56%)
  • Diabetes: Lilly (50%); Novo Nordisk (40%); AstraZeneca (37%)
  • Psoriasis: Leo (65%); Galderma (57%); Janssen (24%)

Past Quick Polls

Remote detailing for pharma – Physicians’ perspectives – Canada

Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.

read more

Does Online Advertising Click for Physicians?

Strong online advertising and messaging are key to maximizing impact of any marketing campaign. With recent restrictions on in-person interactions, online advertising and messaging play an even greater role in reaching physicians. Our findings from a survey of n=227 Canadian physicians show that 82% of Canadian physicians have increased their use of online platforms as a result of COVID-19, 48% significantly so.

read more

Forecasting New Pharma Products – Improving accuracy

Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy.

read more

We are here to answer your questions.

Share This